333. Hutchinson-Gilford syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 8 / Drugs : 8 - (DrugBank : 3) / Drug target genes : 4 - Drug target pathways : 6
Hutchinson-Gilford syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 333 | Hutchinson-Gilford syndrome | - |
| 113 | Muscular dystrophy | 2.288 |
| 34 | Neurofibromatosis | 2.276 |
| 66 | IgA nephropathy | 1.057 |
| 93 | Primary biliary cholangitis | 1.057 |
| 271 | Ankylosing spondylitis | 1.049 |
| 299 | Cystic fibrosis | 1.021 |
| 49 | Systemic lupus erythematosus | 1.018 |
| 96 | Crohn disease | 1.012 |
| 46 | Malignant rheumatoid arthritis | 1.011 |
| 6 | Parkinson disease | 1.011 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 1.008 |